Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis

Eric F. Egelund, Marc H Weiner, Rajendra P. Singh, Thomas J. Prihoda, Jonathan A Gelfond, Hartmut Derendorf, William R. MacKenzie, Charles A. Peloquin

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Rifapentine is highly protein bound in blood, but the free, unbound drug is the microbiologically active fraction. In this exploratory study, we characterized the free plasma fraction of rifapentine in 41 patients with tuberculosis. We found a lower total rifapentine concentration but significantly higher free rifapentine levels in African patients of black race compared to non-Africans. These data support larger pharmacokinetic/pharmacodynamic studies to confirm these findings and assess free rifapentine in relation to microbiological and clinical outcomes.

Original languageEnglish (US)
Pages (from-to)4904-4910
Number of pages7
JournalAntimicrobial Agents and Chemotherapy
Volume58
Issue number8
DOIs
StatePublished - 2014

Fingerprint

rifapentine
Pulmonary Tuberculosis
Protein Binding
Tuberculosis
Pharmacokinetics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis. / Egelund, Eric F.; Weiner, Marc H; Singh, Rajendra P.; Prihoda, Thomas J.; Gelfond, Jonathan A; Derendorf, Hartmut; MacKenzie, William R.; Peloquin, Charles A.

In: Antimicrobial Agents and Chemotherapy, Vol. 58, No. 8, 2014, p. 4904-4910.

Research output: Contribution to journalArticle

Egelund, Eric F. ; Weiner, Marc H ; Singh, Rajendra P. ; Prihoda, Thomas J. ; Gelfond, Jonathan A ; Derendorf, Hartmut ; MacKenzie, William R. ; Peloquin, Charles A. / Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis. In: Antimicrobial Agents and Chemotherapy. 2014 ; Vol. 58, No. 8. pp. 4904-4910.
@article{7d51ff38d0ef4beaba0617272564ef6a,
title = "Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis",
abstract = "Rifapentine is highly protein bound in blood, but the free, unbound drug is the microbiologically active fraction. In this exploratory study, we characterized the free plasma fraction of rifapentine in 41 patients with tuberculosis. We found a lower total rifapentine concentration but significantly higher free rifapentine levels in African patients of black race compared to non-Africans. These data support larger pharmacokinetic/pharmacodynamic studies to confirm these findings and assess free rifapentine in relation to microbiological and clinical outcomes.",
author = "Egelund, {Eric F.} and Weiner, {Marc H} and Singh, {Rajendra P.} and Prihoda, {Thomas J.} and Gelfond, {Jonathan A} and Hartmut Derendorf and MacKenzie, {William R.} and Peloquin, {Charles A.}",
year = "2014",
doi = "10.1128/AAC.01730-13",
language = "English (US)",
volume = "58",
pages = "4904--4910",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis

AU - Egelund, Eric F.

AU - Weiner, Marc H

AU - Singh, Rajendra P.

AU - Prihoda, Thomas J.

AU - Gelfond, Jonathan A

AU - Derendorf, Hartmut

AU - MacKenzie, William R.

AU - Peloquin, Charles A.

PY - 2014

Y1 - 2014

N2 - Rifapentine is highly protein bound in blood, but the free, unbound drug is the microbiologically active fraction. In this exploratory study, we characterized the free plasma fraction of rifapentine in 41 patients with tuberculosis. We found a lower total rifapentine concentration but significantly higher free rifapentine levels in African patients of black race compared to non-Africans. These data support larger pharmacokinetic/pharmacodynamic studies to confirm these findings and assess free rifapentine in relation to microbiological and clinical outcomes.

AB - Rifapentine is highly protein bound in blood, but the free, unbound drug is the microbiologically active fraction. In this exploratory study, we characterized the free plasma fraction of rifapentine in 41 patients with tuberculosis. We found a lower total rifapentine concentration but significantly higher free rifapentine levels in African patients of black race compared to non-Africans. These data support larger pharmacokinetic/pharmacodynamic studies to confirm these findings and assess free rifapentine in relation to microbiological and clinical outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84905397050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905397050&partnerID=8YFLogxK

U2 - 10.1128/AAC.01730-13

DO - 10.1128/AAC.01730-13

M3 - Article

C2 - 24841270

AN - SCOPUS:84905397050

VL - 58

SP - 4904

EP - 4910

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -